Developer docs
API playgroundTry for free, no card

Search company profiles

The VIVA Foundation

Full company profile

uuid00sc3sa

Namestring
The VIVA Foundation
Legal namestring
The VIVA Foundation
Company typeenum
Private
Founded yearint
2002
Descriptiontext

The VIVA Foundation is a U.S. not-for-profit organization dedicated to advancing vascular medicine and intervention through education and research. Founded around 2001, the foundation operates two flagship annual conferences held at Las Vegas venues — VIVA (Vascular InterVentional Advances) and The VEINS (Venous Endovascular INterventional Strategies) — serving interventional cardiologists, interventional radiologists, vascular surgeons, vascular medicine specialists, and allied health professionals with CME-accredited programming, live case demonstrations, and late-breaking clinical trial results.

The foundation's product surface centers on these live events, complemented by the Virtual VIVA app (iOS/Android/web) for live streaming, on-demand access to an archive spanning 2017-2025, CME credit claiming, and interactive features such as Q&A and polling. Additional programs include the VIVA-FDA Townhall webinar series, the World Insights international forum, the Vascular Leaders Forum advocacy program, the Innovation Summits (Red Horizons, Blue Sky Breakfast), the Physicians-in-Training scholarship program, and the Vascular Care Team Symposium for nurses and technologists. The foundation also sponsors pivotal vascular trials including BEST-CLI, EMBOLIZE, REALITY, and XCELL, and publishes consensus statements in journals including Circulation: Cardiovascular Interventions.

The business model combines four revenue streams: tiered conference registration fees (Physicians $895-$1,550; Industry up to $1,795; Military free virtual; combined packages up to $2,790), on-demand content sales, multi-tier commercial supporter funding from medical device companies (Global Premier through Subscriber tiers), and CME certification delivered via ACCME-accredited joint providership with the Academy for Continued Healthcare Learning. Distribution is event-driven and global, leveraging direct website registration, app stores, and an extensive endorsement network including SCAI, SVS, SVM, SVN, AVF, and the Leipzig Interventional Course.

Short descriptiontext

The VIVA Foundation is a U.S. not-for-profit that delivers CME-accredited vascular medicine education through two annual Las Vegas conferences (VIVA and The VEINS), a Virtual VIVA app, and an on-demand content library, serving interventional cardiologists, interventional radiologists, vascular surgeons, and vascular medicine specialists globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPalm Springs, United States
HQ citystring
Palm Springs
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vascular medicine education, continuing medical education, interventional cardiology, vascular surgery training, medical conferences
Industry4 codes
1Healthcare & Clinical Professional Development (CME/CE)
CodeEDAGANAJPrimaryYes
2Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)
CodeEDAAALACPrimaryNo
3Scholarship & Fellowship Foundations and Trusts
CodeEDADAHACPrimaryNo
4Investigator & Site Training / GCP Support
CodeHLAGACAFPrimaryNo
NAICS code3 codes
  • Educational Support Services61171
  • Scientific Research and Development Services5417
  • Voluntary Health Organizations813212
SIC code2 codes
  • Services-Health Services8000
  • Services-Misc Health & Allied Services, Nec8090
Product category
Continuing Medical Education
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Conference Registration Fees
TypeSubscription Recurring
Description

Tuition-based registration for VIVA and The VEINS conferences with tiered pricing based on attendee type (physicians, early career, nurses/techs, military, industry) and timing (early bird, prime, standard).

viva-foundation.org
2Content Sales
TypeOne Time License
Description

Purchase of past conference content including sessions, live cases, and presentations through Virtual VIVA platform for on-demand viewing.

viva-foundation.org
3Commercial Supporter Funding
TypeLicensing Royalties
Description

Educational grants and support from medical device companies including Cook Medical, Gore & Associates, Medtronic, Abbott, Philips, and others at various sponsorship tiers.

viva-foundation.org
4CME Certification
TypeProfessional Services
Description

Continuing medical education credits offered for live attendance (in-person or virtual), with credits available for 2025 and prior years.

viva-foundation.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details9 tiers
1Physicians (U.S. & International)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Early Bird: $895 (ends June 25) | Prime: $1,250 (June 26 – August 27) | Standard: $1,550 (August 28 – October 7)

viva-foundation.org
2Early Career Physicians
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Early Bird: $500 (up to 5 years post-training with proof) | Prime: $750 | Standard: $1,525. Early Career with Leadership Program: FREE (Early Bird)

viva-foundation.org
3PAs/NPs, Non-Physician PhDs
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Early Bird: $625 | Prime: $725 | Standard: $825

viva-foundation.org
4Nurses / Techs / HCPs
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Early Bird: $525 | Prime: $575 | Standard: $625 (requires License / NPI #)

viva-foundation.org
5Active-Duty U.S. Military (Virtual-only)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

$100 for all registration windows (virtual-only registration is FREE)

viva-foundation.org
6Industry Professionals
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Prime/Standard: $1,795 (no requirements)

viva-foundation.org
7The VEINS Conference
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Physicians: $700-$850 | Early Career: $375-$850 | PAs/NPs: $475-$575 | Nurses/Techs: $375-$475 | Military: $50 | Industry: $995 | Virtual: $400

viva-foundation.org
8Combined VIVA + VEINS
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Physicians: $1,375-$1,995 (discounted combined rates) | Early Career: $875-$1,995 | PAs/NPs: $995-$1,295 | Nurses/Techs: $800-$1,000 | Industry: $2,790

viva-foundation.org
9Past Conference Content Purchase
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Content from 2017-2025 available for purchase. 2020 content is free. Content includes sessions, live cases, presentations. CME only available for live attendees or livestream viewers, not on-demand.

viva-foundation.org
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 5 records shown
1The VEINS
Description

Venous Endovascular INterventional Strategies - a comprehensive educational symposium focused on the diagnosis, treatment, and long-term management of venous and lymphatic disease, now in its 16th year.

viva-foundation.org
+4 more records
Core offering1 text field

The VIVA Foundation is a not-for-profit organization that delivers live and on-demand continuing medical education in vascular and endovascular medicine to physicians and allied health professionals. Its core offerings consist of two annual multispecialty conferences (VIVA and The VEINS), the Virtual VIVA mobile app and on-demand content library, CME-accredited programs, the VIVA-FDA Townhall, and specialty tracks such as the Physicians in Training, Vascular Care Team Symposium, and Innovation Summits.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 24 years of continuous endovascular education
+2 more records
Product overview1 text field

The VIVA Foundation operates as a not-for-profit vascular medicine education organization offering a platform-plus-programs model. The core offerings center on two major annual medical conferences: the VIVA Conference (Vascular InterVentional Advances) and The VEINS Conference (Venous Endovascular INterventional Strategies), both held in Las Vegas. These conferences are complemented by the Virtual VIVA App, a mobile and web application providing on-demand access to recorded sessions, live case streaming, and CME credit claiming. Additional programs include the VIVA-FDA Townhall webinar series, World Insights international physician forum, Innovation Summits (Red Horizons and Blue Sky Breakfast) for showcasing new technologies, the Physicians in Training scholarship program, and the Vascular Care Team Symposium for nurses and allied health professionals. The foundation also conducts research initiatives, publishes consensus statements, runs the Vascular Leaders Forum advocacy program, and publishes a vascular medicine study guide. The product ecosystem serves interventional cardiologists, interventional radiologists, vascular surgeons, and vascular medicine specialists through live events, digital content, and professional development resources.

Product and service11 records
1VIVA Conference
CategoryContinuing Medical Education Conference
Description

Annual multispecialty conference on vascular and endovascular medicine that brings together interventional cardiologists, interventional radiologists, vascular surgeons, vascular medicine specialists, and allied health professionals for live case-based education, expert presentations, and ACCME-accredited CME.

2The VEINS Conference
CategoryContinuing Medical Education Conference
Description

Companion annual conference to VIVA focused on venous disease diagnosis and intervention, offered by the same foundation and featuring live cases, expert faculty, and CME-accredited education for the vascular care community.

3Virtual VIVA App
CategoryDigital Medical Education Platform
Description

Mobile application for iOS and Android devices that delivers year-round, on-demand access to VIVA Foundation educational content for physicians and vascular care professionals.

4VIVA Content Library
CategoryOn-Demand Medical Education
Description

On-demand digital library of expert-led presentations, clinical cases, and recorded VIVA sessions available to vascular care professionals for continued education throughout the year.

5VIVA-FDA Townhall
CategoryRegulatory and Clinical Education Program
Description

Collaborative educational program between The VIVA Foundation and the U.S. Food and Drug Administration that provides vascular care professionals with regulatory updates, FDA perspectives, and clinical dialogue on emerging endovascular therapies.

6VIVA World Insights
CategoryInternational Medical Education Program
Description

VIVA Foundation educational program that surfaces international perspectives in vascular and endovascular medicine, extending the foundation's content reach beyond the U.S. audience.

7VIVA Innovation Summits
CategoryContinuing Medical Education Summit Series
Description

VIVA Foundation program of summits, including Red Horizons and Blue Sky Breakfast, that explore emerging technologies and forward-looking topics in vascular intervention for attending physicians and industry partners.

8VIVA Physicians in Training Program
CategoryFellowship and Trainee Education Program
Description

Dedicated VIVA Foundation educational track for fellows and physicians in training in interventional cardiology, interventional radiology, vascular surgery, and vascular medicine, featuring targeted sessions, scholarships, and awards including the VIVA Young Physician Award.

9Vascular Care Team Symposium
CategoryAllied Health Education Symposium
Description

VIVA Foundation symposium dedicated to allied vascular health professionals, including nurses, technologists, and care team members, featuring targeted education and the Vascular Care Team Awards.

10Vascular Leaders Forum
CategoryLeadership and Advocacy Forum
Description

VIVA Foundation forum that convenes vascular care leaders to discuss strategic, policy, and advocacy issues affecting the multidisciplinary vascular care community.

11The VIVA Foundation Study Guide for Vascular and Endovascular Medicine
CategoryMedical Reference Publication
Description

Published educational reference covering vascular and endovascular medicine topics, intended as a structured study and reference resource for practicing physicians and trainees in the vascular specialties.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierMajorTypeOthers
Description

Official endorser of VIVA Foundation educational programs. SCAI members benefit from VIVA education offerings.

Strategic tierMajorTypeOthers
Description

Official endorser of VIVA Foundation. VSS members have access to VIVA educational programming.

Strategic tierMajorTypeOthers
Description

Official endorser of VIVA Foundation educational programs.

Strategic tierAffiliateTypeOthers
Description

Endorsing society of VIVA Foundation educational programming.

Strategic tierAffiliateTypeOthers
Description

Endorsing society of VIVA Foundation, specifically for The VEINS venous disease conference.

6Leipzig Interventional Course (LINC)
Strategic tierAffiliateTypeOthers
Description

International course collaboration and endorsement partnership.

viva-foundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ACHL is the accredited CME provider for VIVA and The VEINS conferences, providing continuing medical education accreditation in accordance with ACCME requirements.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership for early-career scientist funding in vascular science. VIVA Foundation provides special funding in partnership with AHA for postdoctoral fellowships and career development awards.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration on regulatory issues through Vascular Leaders Forum and VIVA-FDA Townhall webinars. VIVA Foundation works with FDA to affect advancement of vascular care through white papers.

10NHLBI (National Heart, Lung, and Blood Institute)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Research partnership for sponsorship and funding of key vascular trials including BEST-CLI and BEST Registry.

viva-foundation.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

The major US professional society for vascular surgeons, an official VIVA endorser. SVS runs its own annual meeting (VAM) covering open and endovascular surgery, making it a broader incumbent in the same physician audience.

TypeBroad incumbent
Description

Official VIVA endorser and the leading interventional cardiology society. SCAI's annual Scientific Sessions and SHOCK conference address a heavily overlapping physician audience with similar CME, late-breaking trial, and live-case formats.

3Leipzig Interventional Course (LINC)
TypeDirect peer
Description

Annual international vascular intervention conference that is an explicit VIVA partner and endorser. LINC serves the same multispecialty interventional community (cardiology, radiology, vascular surgery) with a comparable live-case, late-breaking-trial educational format.

TypeDirect peer
Description

Operates TCT (Transcatheter Cardiovascular Therapeutics), the flagship interventional cardiology meeting and a direct competitor for the same physicians, late-breaking trials, and device-industry sponsorship dollars that anchor VIVA.

TypeBroad incumbent
Description

The largest US cardiology professional society, whose annual Scientific Session and i2 Summit compete with VIVA for interventional cardiologists, industry sponsorships, and late-breaking vascular clinical trial presentations.

TypeEmerging player
Description

Multidisciplinary consortium on pulmonary embolism response, overlapping with VIVA's vascular medicine agenda and sharing faculty/leadership with the VIVA board. A niche but increasingly influential peer in vascular intervention education.

TypeDirect peer
Description

An official VIVA endorser and the dedicated US venous disease society. AVF co-supports The VEINS conference, making it the most direct peer in the venous-endovascular education segment where VIVA competes.

TypeDirect peer
Description

Long-running annual vascular surgery and endovascular intervention symposium in New York, a direct competitor for vascular surgeon and interventionist attendance, live case demonstrations, and medical-device sponsorship.

TypeBroad incumbent
Description

The largest US society representing interventional radiologists, with an annual meeting (SIR Annual Scientific Meeting) that competes directly with VIVA for IR faculty, attendees, and device-company sponsorships in vascular intervention.

TypeDirect peer
Description

Multidisciplinary society focused on critical limb ischemia, overlapping directly with VIVA's vascular surgeon and interventionalist audience. Shares leadership with VIVA's board and runs parallel educational programs in the same clinical area.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The VIVA Foundation

Continuing Medical Educationviva-foundation.org

The VIVA Foundation is a U.S. not-for-profit that delivers CME-accredited vascular medicine education through two annual Las Vegas conferences (VIVA and The VEINS), a Virtual VIVA app, and an on-demand content library, serving interventional cardiologists, interventional radiologists, vascular surgeons, and vascular medicine specialists globally.

What The VIVA Foundation does

The VIVA Foundation is a U.S. not-for-profit organization dedicated to advancing vascular medicine and intervention through education and research. Founded around 2001, the foundation operates two flagship annual conferences held at Las Vegas venues — VIVA (Vascular InterVentional Advances) and The VEINS (Venous Endovascular INterventional Strategies) — serving interventional cardiologists, interventional radiologists, vascular surgeons, vascular medicine specialists, and allied health professionals with CME-accredited programming, live case demonstrations, and late-breaking clinical trial results.

The foundation's product surface centers on these live events, complemented by the Virtual VIVA app (iOS/Android/web) for live streaming, on-demand access to an archive spanning 2017-2025, CME credit claiming, and interactive features such as Q&A and polling. Additional programs include the VIVA-FDA Townhall webinar series, the World Insights international forum, the Vascular Leaders Forum advocacy program, the Innovation Summits (Red Horizons, Blue Sky Breakfast), the Physicians-in-Training scholarship program, and the Vascular Care Team Symposium for nurses and technologists. The foundation also sponsors pivotal vascular trials including BEST-CLI, EMBOLIZE, REALITY, and XCELL, and publishes consensus statements in journals including Circulation: Cardiovascular Interventions.

The business model combines four revenue streams: tiered conference registration fees (Physicians $895-$1,550; Industry up to $1,795; Military free virtual; combined packages up to $2,790), on-demand content sales, multi-tier commercial supporter funding from medical device companies (Global Premier through Subscriber tiers), and CME certification delivered via ACCME-accredited joint providership with the Academy for Continued Healthcare Learning. Distribution is event-driven and global, leveraging direct website registration, app stores, and an extensive endorsement network including SCAI, SVS, SVM, SVN, AVF, and the Leipzig Interventional Course.

The VIVA Foundation firmographics

Firmographics
Name
The VIVA Foundation
Legal name
The VIVA Foundation
Website
https://viva-foundation.org
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
1–10 employees
Short description
The VIVA Foundation is a U.S. not-for-profit that delivers CME-accredited vascular medicine education through two annual Las Vegas conferences (VIVA and The VEINS), a Virtual VIVA app, and an on-demand content library, serving interventional cardiologists, interventional radiologists, vascular surgeons, and vascular medicine specialists globally.
Ownership category
akta.pro rank

The VIVA Foundation industry classification

Industry
Product category
Continuing Medical Education
NAICS
Educational Support Services (61171), Scientific Research and Development Services (5417), Voluntary Health Organizations (813212)
SIC
Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
akta.pro secondary industries
Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Scholarship & Fellowship Foundations and Trusts (EDADAHAC), Investigator & Site Training / GCP Support (HLAGACAF)

Keywords

  • Vascular medicine education
  • Continuing medical education
  • Interventional cardiology
  • Vascular surgery training
  • Medical conferences

Where The VIVA Foundation is headquartered

Location

Headquarters

HQ city
Palm Springs
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The VIVA Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Conference Registration Fees: Tuition-based registration for VIVA and The VEINS conferences with tiered pricing based on attendee type (physicians, early career, nurses/techs, military, industry) and timing (early bird, prime, standard).
  2. Content Sales: Purchase of past conference content including sessions, live cases, and presentations through Virtual VIVA platform for on-demand viewing.
  3. Commercial Supporter Funding: Educational grants and support from medical device companies including Cook Medical, Gore & Associates, Medtronic, Abbott, Philips, and others at various sponsorship tiers.
  4. CME Certification: Continuing medical education credits offered for live attendance (in-person or virtual), with credits available for 2025 and prior years.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goPhysicians (U.S. & International)
SubscriptionPay-as-you-goEarly Career Physicians
SubscriptionPay-as-you-goPAs/NPs, Non-Physician PhDs
SubscriptionPay-as-you-goNurses / Techs / HCPs
SubscriptionPay-as-you-goActive-Duty U.S. Military (Virtual-only)
SubscriptionPay-as-you-goIndustry Professionals
SubscriptionPay-as-you-goThe VEINS Conference
SubscriptionPay-as-you-goCombined VIVA + VEINS
One time/ perpetual licensePay-as-you-goPast Conference Content Purchase

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

The VIVA Foundation product offering

Product offering

Core offering

The VIVA Foundation is a not-for-profit organization that delivers live and on-demand continuing medical education in vascular and endovascular medicine to physicians and allied health professionals. Its core offerings consist of two annual multispecialty conferences (VIVA and The VEINS), the Virtual VIVA mobile app and on-demand content library, CME-accredited programs, the VIVA-FDA Townhall, and specialty tracks such as the Physicians in Training, Vascular Care Team Symposium, and Innovation Summits.

Product overview

The VIVA Foundation operates as a not-for-profit vascular medicine education organization offering a platform-plus-programs model. The core offerings center on two major annual medical conferences: the VIVA Conference (Vascular InterVentional Advances) and The VEINS Conference (Venous Endovascular INterventional Strategies), both held in Las Vegas. These conferences are complemented by the Virtual VIVA App, a mobile and web application providing on-demand access to recorded sessions, live case streaming, and CME credit claiming. Additional programs include the VIVA-FDA Townhall webinar series, World Insights international physician forum, Innovation Summits (Red Horizons and Blue Sky Breakfast) for showcasing new technologies, the Physicians in Training scholarship program, and the Vascular Care Team Symposium for nurses and allied health professionals. The foundation also conducts research initiatives, publishes consensus statements, runs the Vascular Leaders Forum advocacy program, and publishes a vascular medicine study guide. The product ecosystem serves interventional cardiologists, interventional radiologists, vascular surgeons, and vascular medicine specialists through live events, digital content, and professional development resources.

Differentiator

Problem solved

Functional benefit

Brands

  • The VEINS: Venous Endovascular INterventional Strategies - a comprehensive educational symposium focused on the diagnosis, treatment, and long-term management of venous and lymphatic disease, now in its 16th year.
  • VIVA-FDA Townhall
  • World Insights
  • Vascular Leaders Forum
  • CARVE

Products and services

  • VIVA Conference Annual multispecialty conference on vascular and endovascular medicine that brings together interventional cardiologists, interventional radiologists, vascular surgeons, vascular medicine specialists, and allied health professionals for live case-based education, expert presentations, and ACCME-accredited CME.
  • The VEINS Conference Companion annual conference to VIVA focused on venous disease diagnosis and intervention, offered by the same foundation and featuring live cases, expert faculty, and CME-accredited education for the vascular care community.
  • Virtual VIVA App Mobile application for iOS and Android devices that delivers year-round, on-demand access to VIVA Foundation educational content for physicians and vascular care professionals.
  • VIVA Content Library On-demand digital library of expert-led presentations, clinical cases, and recorded VIVA sessions available to vascular care professionals for continued education throughout the year.
  • VIVA-FDA Townhall Collaborative educational program between The VIVA Foundation and the U.S. Food and Drug Administration that provides vascular care professionals with regulatory updates, FDA perspectives, and clinical dialogue on emerging endovascular therapies.
  • VIVA World Insights VIVA Foundation educational program that surfaces international perspectives in vascular and endovascular medicine, extending the foundation's content reach beyond the U.S. audience.
  • VIVA Innovation Summits VIVA Foundation program of summits, including Red Horizons and Blue Sky Breakfast, that explore emerging technologies and forward-looking topics in vascular intervention for attending physicians and industry partners.
  • VIVA Physicians in Training Program Dedicated VIVA Foundation educational track for fellows and physicians in training in interventional cardiology, interventional radiology, vascular surgery, and vascular medicine, featuring targeted sessions, scholarships, and awards including the VIVA Young Physician Award.
  • Vascular Care Team Symposium VIVA Foundation symposium dedicated to allied vascular health professionals, including nurses, technologists, and care team members, featuring targeted education and the Vascular Care Team Awards.
  • Vascular Leaders Forum VIVA Foundation forum that convenes vascular care leaders to discuss strategic, policy, and advocacy issues affecting the multidisciplinary vascular care community.
  • The VIVA Foundation Study Guide for Vascular and Endovascular Medicine Published educational reference covering vascular and endovascular medicine topics, intended as a structured study and reference resource for practicing physicians and trainees in the vascular specialties.

Quantifiable outcome

  • 24 years of continuous endovascular education
  • +2 more outcomes

Companies that use The VIVA Foundation

Customer profile

Named customers6 records

Segments7 records

Ideal customer profiles2 records

The VIVA Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

The VIVA Foundation partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered major, affiliate and core.

  • Society for Cardiovascular Angiography and Interventions (SCAI)majorOthersOfficial endorser of VIVA Foundation educational programs. SCAI members benefit from VIVA education offerings.
  • Society for Vascular Surgery (VSS/Vascular Society)majorOthersOfficial endorser of VIVA Foundation. VSS members have access to VIVA educational programming.
  • Society for Vascular Medicine (SVM)majorOthersOfficial endorser of VIVA Foundation educational programs.
  • Society of Vascular Neurology (SVN)affiliateOthersEndorsing society of VIVA Foundation educational programming.
  • American Venous Forum / Venous Forum (AVF)affiliateOthersEndorsing society of VIVA Foundation, specifically for The VEINS venous disease conference.
  • Leipzig Interventional Course (LINC)affiliateOthersInternational course collaboration and endorsement partnership.
  • Academy for Continued Healthcare Learning (ACHL)coreStrategic or Co-development PartnerACHL is the accredited CME provider for VIVA and The VEINS conferences, providing continuing medical education accreditation in accordance with ACCME requirements.
  • American Heart Association (AHA)majorStrategic or Co-development PartnerPartnership for early-career scientist funding in vascular science. VIVA Foundation provides special funding in partnership with AHA for postdoctoral fellowships and career development awards.
  • FDA (U.S. Food and Drug Administration)majorStrategic or Co-development PartnerCollaboration on regulatory issues through Vascular Leaders Forum and VIVA-FDA Townhall webinars. VIVA Foundation works with FDA to affect advancement of vascular care through white papers.
  • NHLBI (National Heart, Lung, and Blood Institute)majorStrategic or Co-development PartnerResearch partnership for sponsorship and funding of key vascular trials including BEST-CLI and BEST Registry.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

The VIVA Foundation competitors and assessment

Company assessment

Broad incumbents

  • Society for Vascular Surgery (SVS): The major US professional society for vascular surgeons, an official VIVA endorser. SVS runs its own annual meeting (VAM) covering open and endovascular surgery, making it a broader incumbent in the same physician audience.
  • Society for Cardiovascular Angiography and Interventions (SCAI): Official VIVA endorser and the leading interventional cardiology society. SCAI's annual Scientific Sessions and SHOCK conference address a heavily overlapping physician audience with similar CME, late-breaking trial, and live-case formats.
  • American College of Cardiology (ACC): The largest US cardiology professional society, whose annual Scientific Session and i2 Summit compete with VIVA for interventional cardiologists, industry sponsorships, and late-breaking vascular clinical trial presentations.
  • Society of Interventional Radiology (SIR): The largest US society representing interventional radiologists, with an annual meeting (SIR Annual Scientific Meeting) that competes directly with VIVA for IR faculty, attendees, and device-company sponsorships in vascular intervention.

Direct peers

  • Leipzig Interventional Course (LINC): Annual international vascular intervention conference that is an explicit VIVA partner and endorser. LINC serves the same multispecialty interventional community (cardiology, radiology, vascular surgery) with a comparable live-case, late-breaking-trial educational format.
  • Cardiovascular Research Foundation (CRF) / TCT: Operates TCT (Transcatheter Cardiovascular Therapeutics), the flagship interventional cardiology meeting and a direct competitor for the same physicians, late-breaking trials, and device-industry sponsorship dollars that anchor VIVA.
  • American Venous Forum (AVF): An official VIVA endorser and the dedicated US venous disease society. AVF co-supports The VEINS conference, making it the most direct peer in the venous-endovascular education segment where VIVA competes.
  • VEITHsymposium: Long-running annual vascular surgery and endovascular intervention symposium in New York, a direct competitor for vascular surgeon and interventionist attendance, live case demonstrations, and medical-device sponsorship.
  • CLI Global Society: Multidisciplinary society focused on critical limb ischemia, overlapping directly with VIVA's vascular surgeon and interventionalist audience. Shares leadership with VIVA's board and runs parallel educational programs in the same clinical area.

Emerging players

  • PERT Consortium: Multidisciplinary consortium on pulmonary embolism response, overlapping with VIVA's vascular medicine agenda and sharing faculty/leadership with the VIVA board. A niche but increasingly influential peer in vascular intervention education.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

The VIVA Foundation social profiles

Digital presence

The VIVA Foundation compliance and trust

Trust signal

Compliance2 records

The VIVA Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The VIVA Foundation leadership team

Management profile

Number of profiles

Profiles8 records

The VIVA Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The VIVA Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The VIVA Foundation

What does The VIVA Foundation do?

The VIVA Foundation is a not-for-profit organization that delivers live and on-demand continuing medical education in vascular and endovascular medicine to physicians and allied health professionals. Its core offerings consist of two annual multispecialty conferences (VIVA and The VEINS), the Virtual VIVA mobile app and on-demand content library, CME-accredited programs, the VIVA-FDA Townhall, and specialty tracks such as the Physicians in Training, Vascular Care Team Symposium, and Innovation Summits.

Is The VIVA Foundation a public or private company?

The VIVA Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The VIVA Foundation founded?

The VIVA Foundation was founded in 2002. It employs 1 to 10 people.

Where is The VIVA Foundation based?

The VIVA Foundation is headquartered in Palm Springs, United States, in the North America region.

How does The VIVA Foundation make money?

Four revenue lines are on record. Conference Registration Fees are the primary driver. The others are content Sales, commercial Supporter Funding and CME Certification.

Who are The VIVA Foundation's main competitors?

Broad incumbents on record are Society for Vascular Surgery (SVS), Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC) and Society of Interventional Radiology (SIR). Direct peers are Leipzig Interventional Course (LINC), Cardiovascular Research Foundation (CRF) / TCT, American Venous Forum (AVF), VEITHsymposium and CLI Global Society. PERT Consortium is listed as an emerging player.

Does The VIVA Foundation have an API?

No public API is recorded for The VIVA Foundation.

What industry is The VIVA Foundation in?

The VIVA Foundation's product category is Continuing Medical Education. Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of EDAAALAC, Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy). Its NAICS code is 61171 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireLate-Breaking Clinical Trial Results Announced at The VEINS 2026The VIVA Foundation announced late-breaking clinical trial results from VEINS 2026, covering venous disease treatments. Trials reported high ulcer healing rates with cyanoacrylate closure, low major bleeding with mechanical thrombectomy, and improved quality of life with stent placement. Follow-up data and ongoing enrollment were noted.AijournVascular Innovation Takes Center Stage at The VEINS and VIVA 2026The VIVA Foundation announced that 26 clinical trials will be presented at The VEINS and VIVA 2026, held October 3-6 at Bellagio Las Vegas, covering venous and peripheral artery disease. Presentations include results from studies such as the C-TRACT, RAPID-PE, TRUST, and POWER PAD II trials. The full agenda is available at viva-foundation.org/agenda.PR NewswireVascular Innovation Takes Center Stage at The VEINS and VIVA 2026The VIVA Foundation announced that 26 clinical trials will be presented during The VEINS and VIVA 2026, held October 3-6 at Bellagio Las Vegas, covering venous and peripheral vascular disorders. Presentations include results from studies such as BERG02, C-TRACT, RAPID-PE, POWER PAD II, and TRUST. The full agenda is available at viva-foundation.org/agenda.PR NewswireVascular Innovation on Display: The VIVA Foundation Set to Unveil Latest Trial Data at The VEINS and VIVA 2025The VIVA Foundation announced that results from 23 clinical trials in vascular medicine will be presented at The VEINS and VIVA 2025 conferences from November 1-4, 2025, at Wynn Las Vegas. The conferences, marking 23 years of VIVA's premier education in peripheral vascular disease, will feature an international multispecialty faculty delivering live cases, workshops, and expert discussions alongside the trial presentations. The VEINS conference will focus on venous disorders while VIVA covers broader peripheral vascular interventions, providing practitioners access to the latest advances in vascular care.PR NewswireFinal Round of Late-Breaking Clinical Trial Results Announced at VIVA23The VIVA Foundation announced the final results of three late-breaking clinical trials at the VIVA23 conference in Las Vegas, presenting data on vascular intervention devices. The studies highlighted positive safety and efficacy outcomes for BD Interventional's Lutonix 035 drug-coated balloon, Veryan Medical's BioMimics 3D stent, and Endologix LLC's Detour system in treating peripheral artery disease.PR NewswireLate-Breaking Clinical Trial Results Announced at The VEINS 2023The VIVA Foundation announced late-breaking clinical trial results at The VEINS 2023 conference, highlighting the safety and efficacy of several new venous interventions. Key presentations included positive one-year outcomes for Inari Medical's ClotTriever system, successful primary endpoints for the DUO Venous Stent System in the VIVID trial, and promising early safety data for Akura Medical's thrombectomy system.PR NewswireFirst-on-Podium Data from 20 Vascular and Venous Clinical Trials to Be Presented at The VEINS and VIVA 2023The VIVA Foundation announced that first-on-podium data from 20 vascular and venous clinical trials will be presented at the VIVA and The VEINS conferences in Las Vegas from October 30 to November 1, 2023. The presentations will cover results regarding various medical devices and treatments for conditions such as deep vein thrombosis, chronic limb-threatening ischemia, and pulmonary embolism. This event serves as a key educational forum for interventional specialists to review new evidence in peripheral vascular disease.PR NewswireFirst-Ever Late-Breaking Clinical Trial Results Announced at The VEINS 2022The VIVA Foundation announced the results of six late-breaking clinical trials at The VEINS 2022 conference in Las Vegas, focusing on advancements in venous care and intervention. Key findings highlighted the safety and efficacy of Inari Medical's ClotTriever System and Medtronic's Abre stent for treating deep vein thrombosis and venous outflow obstruction, while also presenting early data on Artio Medical's Amplifi system and Penumbra's Indigo Lightning system.PR NewswireFourth and Final Round of Late-Breaking Clinical Trials Announced at VIVA21The VIVA Foundation announced the fourth round of late-breaking clinical trial results at the VIVA21 vascular education symposium held at Wynn Las Vegas, featuring results from four medical device trials. The PROMISE I trial evaluated the LimFlow Deep Vein Arterialization System in 32 U.S. patients, showing 74% amputation-free survival at 6 months and 77% freedom from amputation at 2 years. Additional trials reported positive outcomes for the BioMimics 3D stent (Veryan Medical), Pantheris OCT-imaging atherectomy system (Avinger), and Amplifi vein dilation system (Artio Medical), with all studies demonstrating strong safety and effectiveness profiles in treating peripheral vascular conditions.